Concepedia
Statistics
Publications
17
Citations
1.6K
H-Index
15
Active since
2012
Affiliations
Bayer (Germany)(Current)
Bayer (United States)
Northwestern University
Charité - Universitätsmedizin Berlin
National University Heart Centre Singapore
Luke Bamber is an author at Bayer (Germany) specializing in medicine, pharmacotherapy, and anticoagulant therapy.
Publications per year
2012–2022
Epidemiology of first and recurrent venous thromboembolism in patients with active cancer
Anja Katholing, Stephan Rietbrock, Luke Bamber et al. · Thrombosis and Haemostasis · 2016 · 289 citations
Medicine, Hematology, Oncology +17
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction
Paul W. Armstrong, Carolyn S.P. Lam, Kevin J. Anstrom et al. · JAMA · 2020 · 275 citations · Full text
Pharmacy, Cardiology, Pharmacotherapy +17
Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancer
Alexander Cohen, Luke Bamber, Stephan Rietbrock et al. · Thrombosis and Haemostasis · 2014 · 198 citations
Medicine, Oncology, Clinical Epidemiology +16
The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients
Stefan Cano, Donna L. Lamping, Luke Bamber et al. · Health and Quality of Life Outcomes · 2012 · 115 citations · Full text
Medicine, Internal Medicine, Outcomes Research +16
Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results
Christoph Gerlinger, Luke Bamber, Friedhelm Leverkus et al. · BMC Research Notes · 2019 · 107 citations · Full text
Pharmacy, Health Sciences, Pharmacoeconomics +17
1–5 of 17